Panel Discussion | Challenges and Opportunities for Innovation in 2025

Sunday, March 9, 2025

3:20 PM - 3:35 PM ET

Panel Moderator(s)

Steven R. Bailey, MD, MSCAI

Professor of Medicine
LSU Health Shreveport
San Antonio, Texas, United States

Disclosure(s): No financial relationships to disclose
Yuval Binur, PhD

Managing Partner
Arsuf Global Partners
NEW YORK, New York, United States

No relationships to disclose
Dipti Itchhaporia, MD

Clinical Professor
University of California, Irvine

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Gary M. Ansel, MD, FACC

Founder
Healthcare Inroads
Columbus , Ohio, United States

No relationships to disclose
Mark C. Bates, MD, DSc, FSCAI

Clinical Professor of Medicine and Surgery
CAMC Institute of Academic Medicine and WVU
Charleston, West Virginia, United States

No relationships to disclose
Rafael Beyar, MD, DSc, MPH

Interventional cardiologists and President
Rambam Hospital/ Rambam Friends Organizations
Haifa, Israel

Disclosure information not submitted.
Sundar Chidambaram, MD DNB DM FNB

CONSULTANT INTERVENTIONAL CARDIOLOGIST AND ENDOVASCULAR. SPECIALIST
KAUVERY HOSPITAL, Tamil Nadu, India

No relationships to disclose
Nicolas Foin, MSc, PhD

Founder/ Adj Associate Professor
Dhenin/ Duke-NUS Medical School
Brussels, Brussels Hoofdstedelijk Gewest, Belgium

No relationships to disclose
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States

No relationships to disclose
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

No relationships to disclose
Stanton J. Rowe, PhD

CEO
NXT Biomedical
Irvine, California, United States

No relationships to disclose
Bradley H. Strauss, MD, PhD

Staff Cardiologist
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

No relationships to disclose

Disclosure(s):

Steven R. Bailey, MD, MSCAI: No financial relationships to disclose

Yuval Binur, PhD: No financial relationships to disclose

Dipti Itchhaporia, MD: No financial relationships to disclose

Gary M. Ansel, MD, FACC: akura medical: Consultant (Ongoing); BSC: Consulting Fees (e.g., advisory boards) (Ongoing); Cook Medical: Consultant (Ongoing), royalties (Ongoing); Efemoral Medical, Inc.: Stock-privately held company (Ongoing); Healthcare inroads: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); mercator: Consultant (Terminated, April 1, 2024); Otsuka Pharmaceuticals: Consultant (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing); sentante: Consultant (Ongoing); surmodics: royalties (Ongoing)

Mark C. Bates, MD, DSc, FSCAI: Avobis Bio: Board Chair (Ongoing); WL Gore & Associates: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Rafael Beyar, MD, DSc, MPH: Bio-T: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cuspa medical: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medhub AI: Stock-privately held company (Ongoing)

Sundar Chidambaram, MD DNB DM FNB: No financial relationships to disclose

Nicolas Foin, MSc, PhD: CoreAalst: Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Medinbox: Consultant (Ongoing), Exec. Board, Mandate (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC: AtaCor Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Chaim Shaul Lotan, MD: No financial relationships to disclose

Stanton J. Rowe, PhD: Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

Bradley H. Strauss, MD, PhD: RBY Medical: company founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)